Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
57,323,157
-
Share change
-
-2,093,781
-
Total reported value
-
$239,056,112
-
Price per share
-
$4.17
-
Number of holders
-
96
-
Value change
-
-$34,895,638
-
Number of buys
-
50
-
Number of sells
-
37
Institutional Holders of GENMARK DIAGNOSTICS INC - COM (GNMK) as of Q4 2017
As of 31 Dec 2017,
GENMARK DIAGNOSTICS INC - COM (GNMK) was held by
96 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
57,323,157 shares.
The largest 10 holders included
PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, CADIAN CAPITAL MANAGEMENT, LP, JPMORGAN CHASE & CO, PUTNAM INVESTMENTS LLC, BlackRock Inc., Casdin Capital, LLC, Vanguard Group Inc, HighTower Advisors, LLC, and JENNISON ASSOCIATES LLC.
This page lists
96
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.